NEWS
Date
NORMAN, Okla. – The University of Oklahoma announced today the students named to its fall 2025 honor roll, a distinction given to those who achieve the highest academic standards.
A total of 12,401 students were named to the fall 2025 honor roll. Of these students, 5,156 were named to the President’s Honor Roll for earning an “A” grade in all their courses.
The honor roll recognizes undergraduate students at OU’s Norman campus and OU Health Campus. Most colleges include full-time students who completed at least 12 letter-graded credit hours. Those with a 4.0 grade-point average were named to the President’s Honor Roll. Students with a grade-point average of 3.5 or higher are named to the Dean’s Honor Roll. In the Gallogly College of Engineering and the Mewbourne College of Earth and Energy, students with a grade-point average of 3.0 or higher qualify for recognition.
A searchable honor roll list for fall 2025 is available for download online. Students who are on both the President’s Honor Roll and Dean’s Honor Roll are denoted by an asterisk.
For honor roll inquiries, students in Norman-based programs should contact records@ou.edu; students in Health Campus–based programs should contact admissions@ouhsc.edu.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. For more information about the university, visit www.ou.edu.
The University of Oklahoma College of Medicine has named Kelly Stratton, M.D., FACS as associate dean for veterans affairs, pending approval by the OU Board of Regents.
The University of Oklahoma announced the students named to its fall 2025 honor roll, a distinction given to those who achieve the highest academic standards. A total of 12,401 students were named to the fall 2025 honor roll. Of these students, 5,156 were named to the President’s Honor Roll for earning an “A” grade in all their courses.
A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.
